33 min listen
Manufacturing at the Point of Care with Orgenesis' CEO Vered Caplan
Manufacturing at the Point of Care with Orgenesis' CEO Vered Caplan
ratings:
Length:
37 minutes
Released:
Nov 24, 2022
Format:
Podcast episode
Description
Orgenesis' CEO, Vered Caplan explains the business model behind providing cell and gene therapies that may be manufactured at the point of care. She details how working with hospitals and healthcare providers to enable them to participate in CGT development on their sites and providing these therapies in-house by adapting them to closed system manufacturing rather than relying on the typical biotech model is an important step forward in CGT manufacturing.
Released:
Nov 24, 2022
Format:
Podcast episode
Titles in the series (75)
Cellevolve Bio's Dr. Derrell Porter on the Need for Diversity and Inclusion in Biotech by Cell & Gene: The Podcast